ClinicalTrials.Veeva

Menu

Adapting the FACETS Program to Sickle Cell Disease (Drépa-FACETS)

V

Versailles Hospital

Status

Enrolling

Conditions

Fatigue Symptom
Sickle Cell Disease

Treatments

Other: Drépa-FACETS Program

Study type

Interventional

Funder types

Other

Identifiers

NCT06650813
P23/09 - Drépa-FACETS

Details and patient eligibility

About

Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).

Enrollment

24 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant having freely given his oral agreement.
  • Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
  • Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.

Exclusion criteria

  • Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints.
  • Participants with another chronic pathology causing fatigue.
  • Participants in vaso-occlusive crisis (VOC) or hospitalization.
  • Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

24 participants in 1 patient group

Patients with sickle cell disease
Experimental group
Treatment:
Other: Drépa-FACETS Program

Trial contacts and locations

2

Loading...

Central trial contact

Michalina DANNOUNE; Damien OUDIN-DOGLIONI, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems